FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for A closer look at the unapproved peptide injections promoted by influencers and celebrities king5.com Unauthorized injectable peptide drugs sold by Prime Research may pose serious health risks Canada.ca The wellness world is eager for RFK Jr.'s promised move on peptides : NPR